# Nishant Thalwal

**Life Science Informatics | Biotech Strategy & R&D** |

Deggendorf, Germany

[E-mail](mailto:nishant.thalwal@stud.th-deg.de) | [LinkedIn](https://www.linkedin.com/in/nishant-thalwal/) | [GitHub](https://github.com/Nishant808) | [Portfolio](https://nishant-thalwal.lovable.app)

---

### üéØ Professional Profile

**Biotech Analyst & Data Strategist** bridging the gap between biological data and business decision-making. I combine Biology & Informatics with Finance to support high-impact strategic choices in Pharma and VC.

---

### üõ†Ô∏è Core Competencies

* **Strategic Analysis:** R&D Portfolio Optimization, Capital Allocation, Technical Due Diligence, Risk-Adjusted Valuation (rNPV), Scenario Modeling.
* **Data Science:** Python (Pandas, NumPy, Scikit-learn), Integer Linear Programming (Optimization), SQL, TensorFlow.
* **Bioinformatics:** Clinical Trial Analysis (NCT Data), Pathway Enrichment, Differential Expression (DESeq2), Network Analysis.
* **Tools:** Plotly/Dash, Docker, Snakemake, Excel (Financial Modeling).

---

### üöÄ Strategic Projects (Featured)

**Strategic R&D Portfolio Optimization (Pharma Capital Allocation)** | *Python, ILP, DCF Modeling*
*Engineered a quantitative decision-support framework to allocate a theoretical **‚Ç¨500M fund** across global oncology assets.*

* **Capital Efficiency:** Processed **400,000+ clinical trial records** to isolate a high-signal "Investable Universe," utilizing **Integer Linear Programming (ILP)** to solve for maximum portfolio NPV under strict budget constraints.
* **Risk Pricing:** Applied a **Discounted Cash Flow (DCF)** model using industry-standard cumulative success probabilities (~10% Phase 1 to ~60% Phase 3) to value assets based on clinical maturity.
* **Technical Due Diligence:** Identified and corrected an "Enrollment Arbitrage" data anomaly where observational screening studies were misclassified as high-value therapeutic assets, implementing semantic filters to **de-risk the portfolio** and secure a valid **140% risk-adjusted ROI**.

**CreditWise ‚Äì Loan Risk Prediction** | *Machine Learning, Financial Risk*

* Developed an end-to-end risk assessment pipeline using Gaussian Naive Bayes to predict loan defaults.
* Achieved **86% accuracy** in identifying high-risk profiles, demonstrating transferability of risk modeling from finance to biotech scenarios.

---

### üî¨ Technical & Research Projects

**NetFragile ‚Äì Biological Network Robustness Simulator** | *NetworkX, Plotly*

* Simulated targeted attacks on PPI networks to model drug efficacy; demonstrated that targeting "Hub" proteins collapses the *M. tuberculosis* network **3x faster** than random attacks.
* Built an interactive Dash web app for real-time visualization of network resilience.

**RNA-seq Analysis (LUAD Biomarker Discovery)** | *TensorFlow, SHAP*

* Analyzed **539 TCGA samples** to identify lung adenocarcinoma biomarkers.
* Validated findings via KEGG/GO enrichment, confirming a **400x overrepresentation** in lipid metabolism pathways, translating complex genomic data into clear clinical insights.

---

### üíº Professional Experience

**R&D Intern** | **Drepto Biodevices (IIT Bombay)** | *May 2025 ‚Äì July 2025*

* Contributed to the prototyping and technical documentation of novel medical devices in a high-velocity startup environment.
* Modeled design constraints to support R&D feasibility decisions, gaining direct exposure to the **concept-to-prototype lifecycle**.

**Bioinformatics Intern** | **ArrayGen Technologies** | *Nov 2024 ‚Äì Feb 2025*

* Executed large-scale transcriptomic analysis on 500+ patient samples to isolate immune signaling patterns.
* Delivered actionable data visualizations to senior technical stakeholders to guide research focus.

---

### üéì Education

**M.Sc. Life Science Informatics** | TH Deggendorf, Germany | *Oct 2025 ‚Äì Present*

* *Focus:* Data-Driven Decision Support, Computational Biology, Algorithm Design.

**B.Tech Biotechnology** | VNMKV, India | *Jul 2021 ‚Äì Jul 2025*

* *Performance:* 1.7 (German Scale) / 8.7 GPA.

---

### üåê Languages & Interests

* **Languages:** English (C1 - Professional), German (B1).
* **Interests:** Venture Capital in Biotech, Drug Development Economics, Badminton.

---
